Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Obiora C. Okoye"'
Autor:
Nidhi S. Mundada, Julio C. Rojas, Lawren Vandevrede, Elisabeth H. Thijssen, Leonardo Iaccarino, Obiora C. Okoye, Ranjani Shankar, David N. Soleimani-Meigooni, Argentina L. Lago, Bruce L. Miller, Charlotte E. Teunissen, Hillary Heuer, Howie J. Rosen, Jeffrey L. Dage, William J. Jagust, Gil D. Rabinovici, Adam L. Boxer, Renaud La Joie
Publikováno v:
Alzheimer’s Research & Therapy, Vol 15, Iss 1, Pp 1-13 (2023)
Abstract Background Plasma phosphorylated tau (p-tau) has emerged as a promising biomarker for Alzheimer’s disease (AD). Studies have reported strong associations between p-tau and tau-PET that are mainly driven by differences between amyloid-posit
Externí odkaz:
https://doaj.org/article/3dbc3ee43d5140a18da1d39288aff8ab
Autor:
Nidhi S. Mundada, Elisabeth H Thijssen, Leonardo Iaccarino, Obiora C Okoye, Ranjani Shankar, David N. Soleimani‐Meigooni, Lawren VandeVrede, Argentina Lario Lago, Bruce L. Miller, Charlotte E. Teunissen, Julio C. Rojas, Jeffrey L Dage, Gil D. Rabinovici, Adam L. Boxer, Renaud La Joie
Publikováno v:
Mundada, N S, Thijssen, E H, Iaccarino, L, Okoye, O C, Shankar, R, Soleimani-Meigooni, D N, VandeVrede, L, Lago, A L, Miller, B L, Teunissen, C E, Rojas, J C, Dage, J L, Rabinovici, G D, Boxer, A L & la Joie, R 2022, ' Head-to-head comparison between plasma ptau-217 and Flortaucipir-PET in amyloid-positive patients with cognitive impairment ', Alzheimer's and Dementia, vol. 18, no. S1, e067888 . https://doi.org/10.1002/alz.067888
Alzheimer's and Dementia, 18(S1):e067888. Elsevier
Alzheimer's and Dementia, 18(S1):e067888. Elsevier
Background: Plasma measurements of phosphorylated tau (ptau) have emerged as promising biomarkers for Alzheimer’s disease (AD). Studies have shown strong associations between ptau and tau-PET that are mainly driven by the difference between amyloid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4396d224fefb3612b1b8e8a21f6bbc1b
https://research.vumc.nl/en/publications/aa3cb9b9-79ac-4b7e-8b2f-5101ad41b921
https://research.vumc.nl/en/publications/aa3cb9b9-79ac-4b7e-8b2f-5101ad41b921
Autor:
Nidhi S. Mundada, Julio C. Rojas, Lawren Vandevrede, Elisabeth H. Thijssen, Leonardo Iaccarino, Obiora C. Okoye, Ranjani Shankar, David N. Soleimani-Meigooni, Argentina L. Lago, Bruce L. Miller, Charlotte E. Teunissen, Hillary Heuer, Howie J. Rosen, Jeffrey L. Dage, William J. Jagust, Gil D. Rabinovici, Adam L. Boxer, Renaud La Joie
Background and ObjectivePlasma phosphorylated tau (p-tau) has emerged as a promising biomarker for Alzheimer’s disease (AD). Studies have reported strong associations between p-tau and tau-PET that are mainly driven by differences between amyloid-p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b323135ca279aa2d44bbd3ff1950e211
https://doi.org/10.1101/2022.11.29.22282851
https://doi.org/10.1101/2022.11.29.22282851